Candida lipolytica was recovered from six patients in three different clinical centers. The index isolate caused a persistent fungemia with catheter-associated Candida thrombophlebitis, the second isolate was from a polymicrobial sinusitis, and the remaining four isolates were involved in tissue colonization. These and 20 other isolates were consistent in their morphological and physiological characteristics. Ail formed true hyphae and blastoconidia on cornmeal-Tween 80 agar and all assimilated glucose, glycerol, and erythritol. In a murine model of disseminated candidiasis, the index isolate that caused clinical fungemia caused no mortality and produced only two lesions on a kidney, as determined at necropsy. The nine isolates selected for in vitro antifungal susceptibility studies had interniediate susceptibilities to amphotericin B but were susceptible to ketoconazole. We conclude that C. lipolytica is a weakly virulent pathogen which may require an intravascular foreign body to cause fungemia.
Candida lipolytica (Harrison) Diddens et Lodder has seldom been identified as a cause of infection. When fungemia caused by C. lipolytica developed in one of our patients, we found that there was no single study which examined the clinical manifestations, microbiological features, and in vivo characteristics of this fungus. C. lipolytica was not included in several large case series as a cause of fungemia (3, 7, 8, 13) . Only one well-described case of fungemia (18) and three cases of traumatic ocular infection (11) caused by C. lipolytica have been reported previously. While the morphological and physiological properties of C. lipolytica have been described in standard monographs (2, 10) , little is known about the characteristics of C. lipolytica in the new rapid diagnostic systems for yeasts. There are virtually no studies of the in vitro susceptibility of C. lipolytica to antifungal agents. Finally, with the exception of one study in which a strain from a nonclinical source was used (6) , there were no reported in vivo studies in which the virulence of C. lipolytica has been evaluated.
Since relatively little was known about C. lipolytica, we studied the clinical features of six cases of infection or colonization involving C. lipolytica, investigated the morphological characteristics and biochemical properties of 26 isolates, and evaluated the antifungal susceptibilities of 9 isolates of this yeastlike fungus. We particularly examined the properties of these isolates of C. lipolytica in a new rapid yeast identification systems. We also studied the virulence of the isolate that caused clinical fungemia in experimental animals. Since clinical isolates of C. lipolytica were misidentified as Candida ingens van Microbiological studies. For all microbiological studies, a portion of growth from a stock culture of each isolate was transferred aseptically to fresh Sabouraud glucose agar and incubated for 72 h at 27°C. The morphological features of all isolates were studied by inoculating a portion of each 72-h-old culture onto cornmeal-Tween 80 agar in 100-mmdiameter petri plates. Their assimilation and enzyme profiles were investigated with the API 20C and Yeast-Ident yeast identification kits (Analytab Products). The commercial products were inoculated with colonies from a 72-h-old culture, and the tests were conducted as directed by the manufacturer. In addition, conventional methods were used to study the following characteristics of the isolates: urease activity; glucose fermentation; and assimilation of erythritol, galactose, and growth in vitamin-free medium (15) .
The in vitro susceptibilities on nine isolates to amphotericin B (Fungizone IV; E. R. Squibb & Sons, Princeton, N.J.) were evaluated by a tube dilution procedure (4 The susceptibilities of the same C. lipolytica isolates to ketoconazole (Nizoral; Janssen Pharmaceutica, Piscataway, N.J.) were assessed with an agar dilution series (4, 5 Groups of two male CD-1 mice (Charles River, Breeding Laboratories, Inc., Wilmington, Mass.) each received 0.1 ml of one of the five 10-fold dilution series of each inoculum of each fungus via the lateral tail vein. All mice were housed, maintained, and treated as described in the Guide for the Care and Use of Laboratory Animals (Publication 85-23, National Institutes of Health, Bethesda, Md.). Mice were euthanized when they were moribund; the remaining mice were euthanized at 14 days after inoculation. Brain, liver, spleen, and kidneys were examined postmortem and cultured quantitatively.
RESULTS
Morphological and physiological studies. C. lipolytica formed distinctive cerebriform, convoluted, white, firm colonies on Sabouraud glucose agar (Fig. 1) . All C. lipolytica isolates formed narrow, multibranched, true hyphae on cornmeal-Tween 80 agar. Blastoconidia, which generally developed only after several days of incubation, were found at the apices and less commonly along the length of the hyphae. In contrast, isolates of C. ingens on the same medium formed chains of budding yeast cells and broad pseudohyphae without blastoconidia. No true hyphae were observed in the cultures of C. ingens on cornmeal-Tween 80 agar. (18) of C. lipolytica fungemia were associated with intravenous catheter infections. These two cases suggest that a vascular catheter may be required for the introduction of C. lipolytica into the bloodstream. Although the infected venous catheter was removed from the index patient, fungemia persisted. This persistent fungemia was likely caused by an infected catheter-associated mural thrombus (14, 16, 17 Given the low virulence of C. lipolytica, one must question whether removal of a vascular catheter without the concomitant administration of amphotericin B would be appropriate management of catheter-associated candidemia caused by this organism. Infections in both our patient and the previously reported patient with C. lipolytica fungemia (18) were associated with vascular catheters and neither was apparently complicated by a deep visceral infection. Nevertheless, until more experience is acquired in managing this infection, we suggest that catheter-associated C. lipolytica fungemia be managed in a similar manner as that of other Candida spp. fungemias: a course of systemic antifungal therapy and removal of potentially infected vascular catheters.
Amphotericin B is the cornerstone of treatment of candidemia caused by susceptible Candida spp. The dosage and duration of amphotericin B therapy for candidemia depend on the extent of infection and the type of host. The nine C. lipolytica isolates that we tested were found to be susceptible to achievable concentrations of amphotericin B in serum (0.313 to 1.25 ,ug/ml). These concentrations are usually achieved when amphotericin B is administered intravenously at 0.5 mg/kg per day (1, 9) . If fungemia persists despite amphotericin B therapy, consideration should be given to resection of any potentially infected catheter-associated peripheral venous thrombus.
An antifungal azole, however, may be considered in selected patients as a possible alternative for the treatment of C. lipolytica infections. All isolates tested in this study were susceptible to ketoconazole. The patient reported by Wherspann and Fullbrandt (18) responded successfully to removal of the infected venous catheter and administration of ketoconazole; the patient with sinusitis had an apparent improvement from ketoconazole therapy. Perhaps localized mucosal infections caused by C. lipolytica may be amenable to ketoconazole therapy. However, since the correlation between in vitro and in vivo effects of ketoconazole are often variable (12) and since therapeutic experience with C. lipolytica is limited, such patients treated with ketoconazole require careful selection and follow-up. Investigational antifungal triazoles, such as fluconazole and itraconazole, also may be active against isolates of C. lipolytica and may be more active than ketoconazole. We suggest that antifungal azoles be considered as a possible alternative to amphotericin B in the management of selected patients with C. lipolytica infections.
The results of this investigation of C. lipolytica indicate that (i) C. lipolytica is a weakly virulent pathogen associated with vascular catheter infections, (ià) C. lipolytica is less virulent in experimental animals than is C. albicans, (iii) isolates of C. lipolytica, are susceptible in vitro to amphotericin B as well as to ketoconazole, and (iv) isolates of C. lipolytica demonstrate generally consistent morphological and physiological characteristics.
